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Background: Adherence to screening guidelines has been widely accepted to reduce morbidity, mortality, and
cost outcomes. The aim of this study was to identify predictors of adherence to screening guidelines for
chronic diseases of lifestyle (CDL), cancers, and HIV in a health-insured population in South Africa, some of
whom voluntarily opt into a wellness program that incentivizes screening.
Method: A cross-sectional study for the period 2007 2011 was conducted using a random sample of 170,471
health insurance members from a single insurer. Adherence to screening guidelines was calculated from
medical claims data.
Results: Adherence to screening guidelines ranged from 1.1% for colorectal cancer to 40.9% for cholesterol
screening. Members of the wellness program were up to three times more likely to screen for diseases (odds
ratio [OR] 3.2 for HIV screening, confidence interval [CI] 2.75 3.73). Plan type (full comprehensive plan)
was most strongly associated with cholesterol screening (OR 3.53, CI 3.27 3.80), and most negatively
associated (hospital-only core plan) with cervical cancer screening (OR 0.44, CI 0.28 0.70). Gender was a
negative predictor for glucose screening (OR 0.88, CI 0.82 0.96). Provincial residence was most strongly
associated with cervical cancer screening (OR 1.89, CI 0.65 5.54).
Conclusion: Adherence to screening recommendations was B50%. Plan type, gender, provincial residence,
and belonging to an incentivized wellness program were associated with disproportionate utilization of
screening services, even with equal payment access.
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S
ignificant disparities exist in preventive healthcare
utilization (1). Such disparities are evident not only
between high and low-income populations but also
within seemingly homogenous populations (2 4). It is
well accepted that access to health insurance increases the
uptake of screening services (5 7); however, even within
the insured population with equal access to services, vari-
ation in screening rates exists (8, 9). Inequitable use of
healthcare perpetuates the burden of severe illness and
mortality in people who tend to need healthcare the most
(10). The use of preventive health services, like screening
for asymptomatic diseases, effectively reduces morbidity
and cause-specific mortality (11 13). Several individual-
level factors (level of education, income, age, ethnic
minority, or occupation) (14 17) as well as environmental
factors (overcrowding, low-income neighborhoods, or
lack of a primary care healthcare provider) are negatively
associated with the use of screening services (18 20).
South Africa is often described as one of the most ineq-
uitable countries in the world with marked differences
in rates of disease and mortality along racial, gender,
provincial, and urban rural divides as a consequence
of its former despotic and poorly functioning govern-
ment (21 23). Health organizations thus play an im-
portant role in improving the overall health status
of the population and eliminating health inequality in
South Africa.
Discovery Health, the largest health insurance in
South Africa with an approximately 40% market share,
offers a fully paid screening program for all its members.
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called Vitality. The Vitality program offers its members
incentives to perform various health-screening tests as
well as to participate in other health-enhancing behaviors
like gym attendance and purchasing healthy foods at
partnerstores.Screeningteststhatareincentivized include
those for certain cancers (breast, cervix, and prostate),
chronic diseases of lifestyle (glucose, cholesterol, BMI,
and blood pressure), and the human immunodeficiency
virus (HIV). Members of Vitality pay a fee per month
(approximately $12.33) and receive benefits, like discounts
at network stores, for participating in the program. The
Discovery Health screening program is a fully paid for
service targeting all of its health-insured members, and the
incentives are only offered to those members who join the
Vitality program. Screening targets and guidelines used
are adapted from the United States Preventative Services
Task Force (USPSTF) recommendations.
Even after major health sector reform, South Africa
has only some formal population-based screening policies
(e.g. cervical cancer screening policy) (24), often poorly
implemented with suboptimal uptake (25). A few targeted
programs however do operate in selected institutions,
provinces, via health insurers and through donor-funded
projects. No data exists on the uptake of these programs
or the inequities that drive preventive screening beha-
vior in South Africa. This paper aims to identify the
factors that impact screening for chronic diseases of
lifestyle (CDL), cancers, and HIV in a health-insured
population with equal payment access, some of whom
are exposed to incentives for screening, specific to
South Africa. Knowing the disparities pertaining to
preventive care utilization would enable further research
agendas, relevant and selective messaging to certain
subgroups and could lead to more targeted resource
organization and allocation.
Present investigation
The analysis was a cross-sectional study conducted from
2007 to 2011 based on data collected from Discovery
Health member claims using Current Procedural Termi-
nology (CPT) codes. A random 1% sample, not stratified
across any variables, consisting of 170,471 members, was
generated from the health insurance member database.
The study population consisted of all members who were
eligible for screening tests (which served as the inclusion
criteria), as adapted from the USPSTF recommendations.
Thisis outlined inTable 1. The Vitality programusesthese
adapted screening recommendations to award points.
Materials and methods
The dependent variables were adherence to the Discovery
screening recommendations. These recommendationswere
classified as follows: 1) receipt of a cholesterol test in the
previous 5 years; 2) receipt of aglucose test in the previous
5 years; 3) receipt of a Pap smear in the previous
3 years; 4) receipt of a mammogram in the previous 2
years; 5) receipt of a colon cancer test (fecal occult blood
test, sigmoidoscopy, or colonoscopy) in the previous 5
years; 6) receipt of a prostate specific antigen (PSA) test
inthepreviousyear;7)receiptofaHIVtestintheprevious
year; and 8) receipt of a bone scan in the previous year.
The following independent variables were studied: socio-
demographic factors, such as age and gender; plan type
(comprehensiveplan:thebestbenefitpackage,withhigher
premiums; core plan: only in-hospital benefits, with the low-
est premiums; saver plan (including priority plan): between
Table 1. Current USPSTF recommendations and inclusion criteria
Tests Frequency and age eligibility
Cholesterol Once every 5 years aged 35 , men aged 20 35 should be screened if they are at increased risk for
heart disease
Glucose Adults once every 5 years; more frequently if BP 135/80
Pap smear Women aged 21 65 every 3 years. For women aged 30 65 years who want to lengthen screening
intervals, screening with a combination of cytology, and human papillomavirus testing every 5 years
Mammogram Recommendations for 2002: screening mammography with or without clinical breast examination every
1 2 years for women aged 40 and older
Colorectal cancer
screening
For adults 50 75 years: Colonoscopy every 10 years and sigmoidoscopy once every 5 years Fecal occult
blood: yearly
Prostate specific antigen Current evidence is insufficient to assess the balance of benefits and harms of screening in men younger
than age 75. Screening may be recommended for older men, those with a family history of prostate cancer
and African American men who are at increased risk of death from prostate cancer.
HIV Counseling/screening is recommended for all adults. Frequency of tests not established.
Osteoporosis Women 65 years and older and in younger women whose fracture risk is equal to or greater than that of
a 65-year-old White women who has no additional risk factors. Consideration may be given to women
at age 50 years who are post-menopausal and at increased risk.
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1; Vitality status (belonging to
the wellness program); and province of residence. Current
USPSTF recommendations are shown in Table 2. Permis-
sion to use the data was provided by the head of research
and development at Discovery Vitality and ethical
clearance was received from the Witwatersrand Human
Research Ethics Committee, certificate number M120854.
Statistical analysis
A descriptive analysis of all of the study variables was
performed. The estimated prevalence for undergoing a
screening test during the 2007 2011 study period, with
corresponding 95% confidence intervals (CIs) for each
screening test, was calculated. An analysis of the associa-
tion of the study variables with screening adherence was
performed using the Chi-squared test statistic and Stu-
dent’s t-test, where applicable. Multivariate logistic re-
gression was used to determine which variables were
independent predictors of screening for cholesterol, glu-
cose, Pap smears, mammograms, PSA, colorectal cancer,
osteoporosis, and HIV. The adjusted odds ratio (OR) and
its 95% CI were calculated to measure the strength of the
association. A logistic regression multivariate model was
built using the forward modeling method. All statistically
significant variables (whose bivariate tests were signifi-
cant) were selected for the multivariate analysis. Calcu-
lations were done using the STATA program (Stata
Corporation 12.0), and statistical significance was set at
pB0.05 (p-values are two tailed).
Results
More than 38% of the insured members were aged 18 35
and 33.3% belonged to 36 50 years of age category; both
categories had a 52% female distribution. Over 64% of the
Discovery Health membership belonged to the Vitality
program. The plan types were divided as follows: 40% of
the participants were insured through the comprehensive
plan, 42% were insured through the saver plan, and 16%
were insured through the core plan. The highest propor-
tion of members resided in the better-resourced provinces,
asfollows:43%inGauteng,18%inWesternCape,and13%
in KwaZulu-Natal. These results are depicted in Table 1.
In this sample data, 40.9% of eligible adults were up-
to-date with their cholesterol tests and only 16.6% had
taken a glucose test in the preceding 5 years. The cervical
screening rate was 11.7% in the previous 3 years, while the
breast cancer screening rate was 7.9% in the previous 2
years. The prostate cancer screening rate was 20.6% in the
previous year. Just over 2.2% of eligible females had been
screened for osteoporosis in the previous year. Only 1.1%
of all members aged 50 years and over had been screened
for colorectal cancer in the previous 5 years. The HIV
screening rate was 8.7% in the previous year. These data,
together with eligibility criteria, are shown in Table 3.
Health insurance members were 67% more likely to
have had a cholesterol test in the preceding 5 years if they
belonged to Vitality (OR  1.67), more than 3.5 times
more likely if they had a comprehensive plan (OR 3.53),
and 42% more likely if they lived in Gauteng province
(Gauteng OR 1.42). Comprehensive plan type was also
1See Table 1 for description of plan characteristics.
Table 2. Characteristics of the study sample
Variables Percentage (%)
Age groups (range of years)
18 35 38.5
36 50 33.3
51 60 14.5
 60 13.7
Gender
Male 48
Female 52
Wellness program membership
Vitality members 64.3
Non-vitality members 35.7
Plan type
*Core 16.6
**Saver 42.7
***Comprehensive 40.6
Provincial distribution of health insurance
membership
Gauteng 43.4
Western Cape 18.6
KwaZulu-Natal 13.5
Eastern Cape 12.8
Mpumalanga 4.4
North West 2.3
Free State 2.3
Limpopo 1.3
Northern Cape 0.9
*Unlimited private hospital coverage  Essential coverage for
chronic medicine  Coverage for medical emergencies when travel-
ling in and outside South Africa. Contributions per month: main
member  $153.41; adult dependent  $120.68; child  $61.25.
**Unlimited private hospital coverage  Essential coverage
for chronic medicine  A Medical Savings Account  Coverage for
medical emergencies when travelling in and outside South Africa.
Contributions per month: main member  $206.14; adult
dependent  $162.27; child  $82.39.
***Unlimited private hospital coverage  A choice of a high or no
Medical Savings Account and an unlimited Above Threshold
Benefit  Comprehensive coverage for chronic medicine 
Coverage for medical emergencies when travelling in and
outside South Africa. Contributions per month: main mem-
ber  $350.68; adult dependent  $331.59; child  $70.
Note: KeyCare plan type was excluded from the analyses as the
benefit offering differed too much from the other plan types.
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preceding 5 years, with members being almost twice as
likely to have undergone that screening (OR 1.9). The
negative predictors of glucose tests were gender (males
were22% less likely to havehadaglucose test [OR 0.88])
and core plan type (core plan members were 22% less
likely [OR 0.78]).
Females who were members of Vitality were 78% more
likely to have had a Pap smear compared to non-Vitality
members (OR  1.78); moreover, they were 89% more
likely to have had the test if they lived in Northern Cape
province (OR 1.89). Female core plan holders were 56%
less likely to be up-to-date with their Pap smear tests
(OR 0.44). Female Vitality members were 89% more
likely to be up-to-date with mammography screening
(OR 1.89) and females with a comprehensive plan type
were almost three times more likely to be up-to-date with
mammography screening (OR 2.99). Core plan typewas
a negative predictor of mammography screening; females
holding that type of plan were 66% less likely to be up-to-
date with mammography screening (OR  0.44).
Males over 50 yearswho were members of Vitality were
45% more likely to have had a prostate cancer screening
test(OR 1.45)andwere2.26timesmorelikelytohavehad
that test if they owned a comprehensive plan (OR 2.26).
The only positive predictor of colorectal cancer (CRC)
screening was province of residence, where members were
more than 50% more likely to have had CRC screening
if they lived in KwaZulu-Natal (OR 1.54) with no
negative predictors.
Overall, members of Vitality were more than three
times more likely to have had a HIV test (OR 3.2) and
they were 27% less likely to have had a HIV test if they
owned a core plan (OR 0.73).
Osteoporosis screening decreased by 40% for every 10-
year increase in age (OR 0.6).
Table 4 shows all of the predictive variables, their odds
ratios, and the corresponding confidence intervals.
Discussion
Screening rates among this insured population is low. This
is not an uncommon finding. Even amongst health insur-
ance members where costs of screening tests are paid for
or in settings where screening facilities are easily acces-
sible, researchers have found poor uptake of services (26,
27). Overall, screening rates in this population are far
behind comparable international populations. For exam-
ple, recent 2012 US findings established that 68% of US
adults had a cholesterol test in the preceding 5 years (28),
and some European countries (Germany, Netherlands,
England, and Italy) manage to screenbetween61 and 79%
of females over 50 years for breast cancer biennially (11).
For this health-insured population, belonging to a
wellness program that provides incentives for performing
screening tests is a strong predictor of whether a person
will undergo cholesterol testing, Pap smears, mammo-
grams, prostate cancer screening, and HIV tests. The use
of economic incentives has shown promising results
directing patients towards health-enhancing behaviors
(29, 30). Positive incentives that reward behavior, rather
than negative incentives that are punitive if certain goals
are not achieved, tend to achieve greater success (31).
Financial incentives can effectively increase the use of
Table 3. Proportion of members up-to-date with preventive screening 2007 2011
Tests
(eligibility criteria for Vitality Screening Program)
Adapted recommendation as per Discovery
Health screening program
Proportion of
eligible members
who screen (%) Confidence interval
Cholesterol (adults ]18 years, n 20 859) Adults once every five years 40.9 40.25 41.56
Glucose (adults ]18 years, n 21 517) Adults once every five years 16.6 16.01 17.07
Pap smear (females ]16 years,
n 2529)
Once every three years 11.7 10.5 12.9
Mammogram (females ]35 years, n 827) Once every two years 7.9 6.1 9.8
Colorectal cancer screening (adults ]50
years, n 4963)
For adults 50 years and older:
Colonoscopy and sigmoidoscopy:
once every five years
Fecal occult blood: yearly
1.1 0.8 1.4
Prostate-specific antigen (males ]50
years, n 107)
Yearly Mean 2007 2011 27.4 25.6 29.2
In the previous year 20.6 12.8 28.3
HIV (adults ] 18 years, n 20 859) Yearly Mean 2007 2011 5.4 5.1 5.7
In the previous year 8.7 8.1 9.3
Osteoporosis (females ]60 years, n 46) Yearly Mean 2007 2011 6.6 5.2 7.9
In the previous year 2.2 1.7 2.7
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Adjusted OR (CI)
Cholesterol Glucose Pap smear Mammogram PSA CRC HIV Bone scan
Age Per 10 year
increase: 1 (ref)
Per 10 year
increase: 1(ref)
Not Significant Per 10 year
increase: 1 (ref)
Per 10 year
increase: 1 (ref)
Not significant Per 10 year
increase: 1 (ref)
Per 10 year
increase: 1 (ref)
1.04 (1.03 1.04) 1.3 (1.29 1.35) 1.42 (1.16 1.74) 1.29 (1.16 1.44) 0.73 (0.69 0.76) 0.6 (0.39 0.92)
Gender Female: 1 (ref) Female: 1 (ref) _ _ _ Not significant Not significant _
Male: 1.14
(1.08 1.21)
Male: 0.88
(0.82 0.96)
Vitality member Non-member: 1
(ref)
Non-member: 1
(ref)
Non-member: 1 (ref) Non-member: 1
(ref‘)
Non-member: 1
(ref)
Not significant Non-member: 1
(ref)
Not significant
1.67 (1.57 1.76) 1.22 (1.13 1.31) 1.78 (1.4 2.3) 1.89 (1.13 3.17) 1.45 (1.20 1.73) 3.2 (2.75 3.73)
Plan
Type
Core 1.56 (1.44 1.68) 0.78 (0.69 0.86) 0.44 (0.28 0.70) 0.44 (0.17 1.12) Not Significant Not Significant 0.73 (0.63 0.98) Not significant
Saver 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Comprehensive 3.53 (3.27 3.80) 1.9 (1.73 2.12) Not significant 2.99 (1.72 5.24) 2.26 (1.6 3.1) Not Significant 0.85 (0.73 0.98) Not significant
Province Eastern Cape: 1
(ref))
Eastern Cape 1
(Ref)
Eastern Cape: 1
(ref)
Eastern Cape: 1
(ref)
Eastern Cape: 1
(ref)
Eastern Cape: 1
(ref)
Gauteng: 1.42
(1.26 1.61
0.84)
Gauteng: 0.99
(0.82 1.14)
Northern Cape 1.89
(0.65 5.54)
Not Significant Gauteng 1.22
(0.83 1.79)
KwaZulu-Natal 1.54
(0.49 4.88)
Gauteng 1.32
(0.99 1.77)
Not significant
Adjusted odds ratios using multivariate logistic regression model, adjusted for age, gender, Vitality member, plan type, and Province of residence.
OR: odds ratio; CI: confidence interval; Comp: comprehensive plan type; Ref: reference value; PSA: prostate-specific antigen; CRC: colorectal cancer.
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)preventive services, like mammography screening, Pap
smears, and colorectal cancer screening (32), although
incentives tend to be more effective for simpler behav-
iors, like influenza vaccinations, than complex behaviors
(29, 33). The type of incentive does not seem as important
as the nature of the incentive (i.e. how relevant the in-
centive is to the person) and researchers are still unsure
what size of incentive has the best outcome (33). In this
study’s population, Vitality members receive discounts at
stores for goods like electronic equipment, books, airline
flights, car rentals, and discounted holidays. Exposure to
incentives in this population may further perpetuate the
inequitable use of preventive care services.
The comprehensive plan is one of the most expensive
plan types offered by this health insurer, possibly making
it affordable for a more affluent part of the membership.
This plan type was associated with cholesterol, glucose,
Pap smears, mammograms, prostate and cancer. In this
population, the finding of a positive association between
the comprehensive plan type and some of the screening
tests is similar to the findings from other studies that have
shown a positive correlation with income level (and level
of education), and rates of cervical cancer and prostate
cancer screening in particular (34 36). The tests that had
the strongest correlations with the comprehensive plan
were cholesterol, mammography and prostate cancer
screening. In South Africa, breast cancer is more com-
mon in the white population (37) and thus this particular
population may be requesting/receiving better healthcare
screening.
Being male was a negative predictor of glucose screen-
ing. This was the only test where males had a lower
likelihood of screening whereas in general, males have
been shown to use preventive services less often than
females (38).
Provincial location was a positive predictor for choles-
terol testing, Pap smears, mammograms, PSA, and HIV
tests. Geographical variation in the use of screening ser-
vices occurs in many countries and is often due to unequal
resource availability and access as well as differing pro-
vider organizations, policies, financial arrangements,
skills, and capacity (1, 19, 20, 35). Wide variations exist
inhealthcareutilizationandhealthoutcomesacrossSouth
African provinces (39). This study further confirms that
eveninthishealth-insuredcommunitywithequalpayment
accessforscreeningservices,provincial locationisastrong
predictor of service utilization.
Owning a hospital plan (core plan) was negatively
associated with glucose screening, Pap smears, mammo-
grams, and HIV tests. Low-socioeconomic status has been
implicitly linked to decreased use of preventive health
servicesinmanyotherstudies,whichcanbeexplained bya
combination of factors like low income, lower levels of
education, being uninsured, and having limited access to a
primary care provider (40). Even in a seemingly homo-
geneous population (like a health-insured membership
such as this), disparities exist in the use of healthcare re-
sources and these are often related to personal predictors
(3). The lower socioeconomic strata of this population
were shown to be at increased risk of not screening, in
particular, for cervical and breast cancer.
Current USPSTF recommendations find no mortality
benefit in screening males younger than age 75 and indeed
screening may be associated with harms related to over-
evaluation (41). Glucose and cholesterol screening has
been shown to have no real benefit when implemented at
population level, with benefits yielded when screening
is targeted at high risk individuals (42, 43). Osteoporosis
research has shown that no trials to date have directly
evaluated effectiveness, harms, and intervals in females
younger than age 65 (44). Although Discovery has
adapted some of the USPSTF recommendations to suit
their target population, they have to date not undertaken
any research to evaluate potential harms that may have
occurred as a result of these screening recommenda-
tions. Further research is required to fully understand the
impact of these recommendations.
Limitations
This study provides no new information about the pre-
dictors of preventive screening services utilization, but
highlights vulnerable subgroups of the population specific
to the South African health-insuredmarket. The study is a
cross-sectional study on the associated factors relating to
screening tests and thus cannot make inferences about the
direction of the cause-and-effect of the factors found
to be associated with those screening tests. The random
sample included test for both asymptomatic screening
as well as for diagnostic purposes as no distinction could
be made based on the CPT code. Screening for asympto-
matic diseases may thus be inflated. People self-select
into the wellness program creating a selection bias; never-
theless, strong associations were identified for many of
the screening tests and belonging to the incentivized
program. Screening recommendations are not exactly as
per USPTF but an adaptation according to the context of
Discovery Health’s population and resources. Compar-
ison to other populations’ screening rates thus cannot
be done specifically for cardiovascular disease screening.
Furthermore, the study’s participants represent a very
select sample of the South African population and infer-
ences about the results cannot be applied to the general
population. However, this is the first study of its kind
evaluating predictors of screening behavior in a South
African population.
Conclusion
In this health-insured population with equal payment
access for screening services, significant variations exist
in the utilization of preventive screening care based on
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location. This confirms that payment for screening ser-
vices alone is not enough to promote utilization. Several
other underlying sociodemographic and health resource
organizational influences that require further research in
this population tend to steer screening behavior.
Owning a certain health plan (either an expensive plan
or a cheaper plan) is a predictor of inequitable healthcare
utilization, possibly favoring the white affluent member,
while males are at particular risk of not screening for
chronic diseases of lifestyle.
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